Literature DB >> 15719030

Detection and interpretation of altered methylation patterns in cancer cells.

Toshikazu Ushijima1.   

Abstract

Epigenetic alterations, such as abnormal DNA-methylation patterns, are associated with many human tumour types. New techniques have been developed to perform genome-wide screening for alterations in DNA-methylation patterns, not only to identify tumour-suppressor genes, but also to find patterns that can be used in diagnosis and prognosis. However, interpretation of differential methylation has proven difficult because the significance of methylation alterations depends on the genomic region, and functions of CpG islands at specific sites have not been fully clarified. What techniques can be used to identify new tumour suppressors and diagnostic markers?

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15719030     DOI: 10.1038/nrc1571

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  145 in total

Review 1.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

2.  Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer.

Authors:  Yoshichika Oishi; Yoshiyuki Watanabe; Yoshihito Yoshida; Yoshinori Sato; Tetsuya Hiraishi; Ritsuko Oikawa; Tadateru Maehata; Hiromu Suzuki; Minoru Toyota; Hirohumi Niwa; Michihiro Suzuki; Fumio Itoh
Journal:  Tumour Biol       Date:  2011-12-08

3.  DNA methylation biomarkers for lung cancer.

Authors:  Tibor A Rauch; Zunde Wang; Xiwei Wu; Kemp H Kernstine; Arthur D Riggs; Gerd P Pfeifer
Journal:  Tumour Biol       Date:  2011-12-06

4.  Hypermethylation of CpG islands is more prevalent than hypomethylation across the entire genome in breast carcinogenesis.

Authors:  Jianxin Tan; Yumei Gu; Xiaomei Zhang; Sihong You; Xiaowei Lu; Senqing Chen; Xiao Han; Yujie Sun
Journal:  Clin Exp Med       Date:  2012-01-04       Impact factor: 3.984

Review 5.  Characterising the epigenome as a key component of the fetal exposome in evaluating in utero exposures and childhood cancer risk.

Authors:  Akram Ghantous; Hector Hernandez-Vargas; Graham Byrnes; Terence Dwyer; Zdenko Herceg
Journal:  Mutagenesis       Date:  2015-02-26       Impact factor: 3.000

Review 6.  Advances in the molecular genetics of acute leukemia.

Authors:  Joseph M Scandura
Journal:  Curr Oncol Rep       Date:  2005-09       Impact factor: 5.075

7.  Comparative isoschizomer profiling of cytosine methylation: the HELP assay.

Authors:  Batbayar Khulan; Reid F Thompson; Kenny Ye; Melissa J Fazzari; Masako Suzuki; Edyta Stasiek; Maria E Figueroa; Jacob L Glass; Quan Chen; Cristina Montagna; Eli Hatchwell; Rebecca R Selzer; Todd A Richmond; Roland D Green; Ari Melnick; John M Greally
Journal:  Genome Res       Date:  2006-06-29       Impact factor: 9.043

Review 8.  Applying whole-genome studies of epigenetic regulation to study human disease.

Authors:  J D Lieb; S Beck; M L Bulyk; P Farnham; N Hattori; S Henikoff; X S Liu; K Okumura; K Shiota; T Ushijima; J M Greally
Journal:  Cytogenet Genome Res       Date:  2006       Impact factor: 1.636

9.  Methylation of multiple genes in gastric glands with intestinal metaplasia: A disorder with polyclonal origins.

Authors:  Mami Mihara; Yukinari Yoshida; Tetsuya Tsukamoto; Ken-ichi Inada; Yukihiro Nakanishi; Yukiko Yagi; Kohzoh Imai; Takashi Sugimura; Masae Tatematsu; Toshikazu Ushijima
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 10.  The role of 5-hydroxymethylcytosine in human cancer.

Authors:  Gerd P Pfeifer; Wenying Xiong; Maria A Hahn; Seung-Gi Jin
Journal:  Cell Tissue Res       Date:  2014-05-10       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.